MOTS-C 10mg

MOTS-C is a mitochondrial-derived peptide, distinct from the synthetic analogues that make up most research peptides, studied within Australian peptide research for its role in metabolic signalling.

Mots C peptide is the same compound as MOTS-C — the hyphen is simply dropped in common usage, and it also appears written as MOTSC. All three refer to the mitochondrial-derived peptide PhaseOne supplies in 10mg vials for laboratory research use only.

PhaseOne ships MOTS-C Australia-wide for research use, dispatched locally with tracking, in 10mg vials. Every vial carries a batch-specific Certificate of Analysis verifying ≥99% HPLC purity.

Yes. MOTS-C is available to buy in Australia from research peptide suppliers such as PhaseOne, supplied as a lyophilised powder for laboratory research. It is not sold through pharmacies or retail outlets, and PhaseOne dispatches Australian orders locally rather than shipping from overseas.

Yes — PhaseOne has MOTS-C peptide for sale online, shipped Australia-wide. Ordering online is the standard route for research peptides in Australia, and every vial ships with its batch Certificate of Analysis so purity can be verified on arrival.

The practical test is documentation. Look for a supplier that publishes batch-specific third-party HPLC results rather than a generic purity claim, dispatches within Australia, and states purity as a verified figure. PhaseOne supplies MOTS-C at ≥99% verified purity with a COA for every batch. (!) View our COA library.

PhaseOne prices MOTS-C at A$63.99 for a 10mg vial, with the batch Certificate of Analysis included at no extra cost. Current pricing is shown on this page.

No. MOTS-C is not registered on the ARTG and is not approved for supply as a medicine in Australia, so Chemist Warehouse and other Australian chemists do not stock it. It is supplied as a research compound through research suppliers instead.

They are grouped together as metabolic peptides but are mechanistically unrelated. GLP-1 compounds such as Retatrutide and Tirzepatide act on incretin receptors; MOTS-C is encoded in the mitochondrial genome and acts through mitochondrial signalling. (!) Read our MOTS-C vs GLP-1 comparison.

Different categories entirely. CJC-1295 is a GHRH analogue studied on the growth hormone axis, while MOTS-C is a mitochondrial-derived peptide studied in metabolic signalling. PhaseOne supplies both. (!) View our CJC-1295 No DAC.

Laboratory interest in MOTS-C commonly centres on mitochondrial signalling and metabolic regulation research, an emerging area within the broader research peptide field. (!) Explore our metabolic peptide guide.

Unreconstituted MOTS-C should be stored refrigerated and protected from light, and is commonly reconstituted with bacteriostatic water prior to research use. (!) Read our reconstitution guide.

Each PhaseOne batch is independently verified by third-party HPLC analysis, with a Certificate of Analysis available on request for every order shipped across Australia.

MOTS-C is currently supplied in 10mg vials, shipped Australia-wide with full batch documentation.

MOTS-C's metabolic signalling research is sometimes considered alongside other longer-chain metabolic peptides such as Retatrutide, though the two have distinct mechanisms. (!) View our Retatrutide.